NPR Health - Shots

AUGUST 13, 2022

As more states restrict abortion, the obstacles for minors who need the procedure are growing. Abortion-rights advocates warn the legal upheaval is leaving young people confused and without options.

135

135

Drug Patent Watch

AUGUST 13, 2022

Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Veloxis Pharms drug ENVARSUS XR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

NPR Health - Shots

AUGUST 13, 2022

NPR's Daniel Estrin speaks to Elizabeth Estrada of the National Latina Institute for Reproductive Justice about the spread of abortion misinformation in the Latino community.

100

100

Drug Patent Watch

AUGUST 13, 2022

Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…. The post New patent for Novartis drug MAYZENT appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Clinical Research

NPR Health - Shots

AUGUST 13, 2022

Adventurer, Bear Grylls, explains what to do when fear kicks in and how to survive in life or if you ever find yourself in a real wilderness-related survival scenario.

57

57

Drug Patent Watch

AUGUST 13, 2022

Annual Drug Patent Expirations for BYFAVO Byfavo is a drug marketed by Acacia and is included in one NDA. There are ten patents protecting this drug. This drug has forty-four…. The post New patent for Acacia drug BYFAVO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

Drug Patent Watch

AUGUST 13, 2022

This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Italy. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Italy? appeared first on DrugPatentWatch - Make Better Decisions.

52

52